Myriad Genetics Inc. Earnings Advance 2% In Q3

(RTTNews) - Myriad Genetics Inc. (MYGN) revealed a profit for its third quarter that increased compared to the same period last year.

The company said its bottom line came in at $29.8 million, or $0.41 per share. This was up from $29.3 million, or $0.40 per share, in last year's third quarter.

Analysts had expected the company to earn $0.38 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company said revenue for the quarter rose 5.8% to $190.5 million. This was up from $180.0 million last year.

Myriad Genetics Inc. earnings at a glance:

-Earnings (Q3): $29.8 Mln. vs. $29.3 Mln. last year. -Earnings Growth (Y-o-Y): 1.7% -EPS (Q3): $0.41 vs. $0.40 last year. -EPS Growth (Y-o-Y): 2.5% -Analysts Estimate: $0.38 -Revenue (Q3): $190.5 Mln vs. $180.0 Mln last year. -Revenue Change (Y-o-Y): 5.8%

-Guidance: Next quarter EPS guidance: $0.36 - $0.38 Next quarter revenue guidance: $186 - $188 Mln Full year EPS guidance: $1.63 - $1.65 Full year revenue guidance: $753 - $755 Mln